# Effect of DAPAglifozin on MYOcardial Remodeling of Breast CANCER Patients Treated with Anthracycline Based Chemotherapy

> **NCT06711185** · PHASE3 · RECRUITING · sponsor: **University of Campinas, Brazil** · enrollment: 80 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Dapagliflozin 10 mg
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06711185
- **Lead sponsor:** University of Campinas, Brazil
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-30
- **Primary completion:** 2026-01-30
- **Final completion:** 2026-08-30
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2024-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06711185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06711185, "Effect of DAPAglifozin on MYOcardial Remodeling of Breast CANCER Patients Treated with Anthracycline Based Chemotherapy". Retrieved via AI Analytics 2026-07-29 from https://api.ai-analytics.org/clinical/NCT06711185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*